Biotech Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin Co. Ltd. to Develop Dotinurad in Additional Territories Including Turkey and the Middle East and North Africa December 14, 2022
Biotech Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial December 14, 2022
Biotech Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer December 14, 2022
Biotech Eiger Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2023 to Discuss Your Rights – EIGR December 13, 2022
Biotech Bears are Losing Control Over Galectin Therapeutics Inc. (GALT), Here’s Why It’s a ‘Buy’ Now December 13, 2022
Biotech ContraFect Announces Pricing of $7.0 Million Registered Direct Offering and Concurrent Private Placement December 13, 2022
Biotech Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi(TM) for In-Office Pupil Dilation December 13, 2022
Biotech Arbutus Completes Enrollment in its Phase 2a Clinical Trial Combining AB-729 with NA Therapy and Peginterferon alfa-2a in Patients with Chronic Hepatitis B Virus Infection December 13, 2022